Entering text into the input field will update the search result below

Buy Signals - ABCD CACB NAVB

Jul. 15, 2015 10:54 AM ETABCD, CACB, NAVB
Jim Van Meerten profile picture
Jim Van Meerten's Blog
66.05K Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Today I added Cambium Learning Group (ABCD), Cascade Bancorp (CACB) and Navidea Biopharmaceuticals (OTCPK:NAVB) to the Barchart Van Meerten Speculative portfolio for superior price performance.

Cambium Learning Group

Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 11 new highs and up 19.58% in the last month
  • Relative Strength index 80.83%
  • Barchart computes a technical support level at 4.80%
  • Recently traded at 5.06 with a 50 day moving average of 4.01


Cascade Bancorp

Barchart technical indicators:

  • 96% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 13 new highs and up 7.85% in the last month
  • Relative Strength Index 67.49%
  • Barchart computes a technical support level at 5.27
  • Recently traded at 5.40 with a 50 day moving average of 5.05


Navidea Biopharmaceuticals

Barchart technical indicators:

  • 88% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 13 new highs and up 21.19% in the last month
  • Relative Strength Index 78.03%
  • Barchart computes a technical support level at 1.65
  • Recently traded at 1.82 with a 50 day moving average of 1.48

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You